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Introductory paragraph 
 Double-stranded DNA (dsDNA) can trigger type I interferon (IFN) production in plasmacytoid 
dendritic cells (pDCs) by binding to endosomal Toll-like receptor-9 (TLR9)1-5. It was recently 
shown that complex formation between DNA and antimicrobial peptides can lead to autoimmune 
diseases via amplification of pDC activation1,2. Here, we demonstrate that a broad range of 
cationic molecules can lead to similar effects, and elucidate the criterion for TLR9 activation by 
combining synchrotron x-ray scattering, computer simulations, and measurements of pDC IFN 
production. TLR9 activation depends crucially on both the inter-DNA spacing and the 
multiplicity of parallel DNA ligands in the self-assembled liquid-crystalline peptide-DNA 
complex. Molecular complexes that present a 2-D grill-like arrangement of DNA at the optimum 
spacing can interlock with multiple TLR9 like a zipper, and lead to multivalent electrostatic 
interactions that drastically amplify binding and thereby the immune response. Our results 
suggest that it is possible to control TLR9 activation and modulate immune responses 
deterministically. 
Main Text 
TLR9 binding of DNA is complex and multi-factorial1-4. Microbial DNA is typically transported 
into intracellular compartments during the process of infection and triggers IFN-α production in 
pDCs via the binding of unmethylated CpG motifs to endosomal TLR9. Host-derived (Self)-
DNA released in the context of cell death can also activate TLR9 in pDC via its sugar backbone4, 
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but this does not normally occur due to the limited access of extracellular self-DNA to 
endosomal compartments5. However, in autoimmune diseases such as psoriasis1 and lupus2, self-
DNA can form complexes with the antimicrobial peptide (AMP) LL37, and potently activates 
TLR9 in pDCs leading to type I IFNs production and disease exacerbation. Recent findings 
posed a significant challenge to understanding immune responses modulated by TLR9: other 
antimicrobial peptides including human defensins HBD2 and HBD36, and several chromatin-
derived proteins can form complexes with DNA and promote TLR9 binding7 and activation8,9. 
One possibility is that complex formation can protect self-DNA from enzymatic degradation10, 
and thereby enable endosomal access required for TLR9 receptor binding. However, this process 
is not sufficient for activation in pDCs, since other peptides complexed with DNA are unable to 
activate TLR9. At present, the selection criteria for TLR9 activation by complexed DNA are not 
understood.  
 
Here, we show why a broad range of cationic molecules besides LL37 can complex with DNA 
and trigger interferon production in pDCs, while many other cationic molecules do not. We 
delineate the governing physical criterion for such high interferon secretion, by combining 
synchrotron Small Angle X-ray Scattering (SAXS), fluorescence microscopy, computer 
simulations, and measurements of IFN-α production by pDCs. Both IFN-inducing and non-IFN 
inducing cationic molecules form complexes with DNA and transport it into TLR9 containing 
endosomes of pDC.  The key determinant for activation is the self-assembled structure of the 
liquid-crystalline peptide-DNA complex, especially the inter-DNA spacing between parallel 
DNA ligands. Using a coarse-grained computational model we show that electrostatic 
4 
 
interactions between TLR9 and DNA are optimized when DNA columnar complexes have an 
inter-DNA spacing that is commensurate with the steric size of TLR9 receptors – allowing for 
‘interdigitation’ of multiple receptors and ligands like teeth in a zipper. The presentation of 
optimally-spaced, parallel DNA ligands results in a new form of multivalent interaction11 that 
drastically increases the number of active, ligand-bound receptors and thereby leads to potent 
IFN induction in pDCs.  
 
We first assess the relationship between pDC activation and the structure of DNA complexes by 
using three prototypical examples of DNA-peptide complexes. HIV TAT is a polycationic 
peptide that can penetrate cells12 and gain endosomal access. We find that incubation of pDCs 
with TAT-DNA complexes does not produce significant levels of IFN-α in pDCs  (Fig. 1). TAT-
DNA complexes efficiently enter TLR9-containing endosomal compartments (Fig. 2b), however, 
suggesting that endosomal access is not sufficient for strong IFN induction in pDCs. SAXS 
measurements show that DNA is organized into a columnar arrangement within TAT-DNA 
complexes similar to many phases of DNA (and other biological polyelectrolytes) condensed by 
multivalent cations13. Diffraction peaks from TAT-DNA complexes are observed at q100 = 2.48 
nm-1, q101 = 3.08 nm-1, and q110 = 4.41 nm-1 (Fig. 1a), characteristic of a columnar hexagonal 
lattice with parameters a = 2.90 nm, c = 3.50 nm (Fig. 3d)14, which corresponds to a bundle-like 
complex with close-packed DNA. Like TAT peptide, human β-defensin-3 (HBD3) is 
polycationic, and is capable of condensing DNA and accessing TLR9 in endosomes (Fig. 2b). In 
contrast to TAT peptide, HBD3-DNA complexes induce strong ~2200 pg/ml IFN-α production 
in pDCs, which is ~100x higher than IFN-α production from TAT-DNA complexes, consistent 
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with extant results6. SAXS measurements (Fig. 1a) show that DNA within HBD3-DNA 
complexes also form a columnar phase. A DNA correlation peak is observed at qDNA = 1.92 nm-
1, indicating that the inter-DNA spacing in HBD3-DNA complexes is 3.25 nm which is 
considerably larger than the spacing in TAT-DNA complexes. Likewise, we find that LL37, 
which accesses TLR-containing endosomes (Fig. 2b) and induces high levels of IFN-α 
production in pDCs (Fig. 1b), also self-assembles with DNA into a columnar structure with an 
inter-DNA spacing aDNA = 3.40 nm (Fig. 3a&b) significantly larger than the DNA diameter. 
These measurements suggest that the inter-DNA spacing in liquid crystalline columnar DNA-
complexes correlates with induced IFN-α production by pDCs. 
 
To test this hypothesis, we measured pDC activation for a broad range of self-assembled DNA 
complexes with different inter-DNA spacings by repeating the above analysis with a diverse set 
of natural and synthetic cationic agents, including peptides (R9, TAT, polylysine (MW ~ 
70,000), hBD3d, NLS, penetratin, HBD3, LL37) as well as non-peptide cationic molecules 
(hexamine cobalt, tris(ethylenediamine) cobalt, protamine sulfate, PEI750k, PAMAM 
dendrimers (G3, G4, G6)) (Supplementary Table S1). SAXS measurements show these cationic 
agents condense DNA into ordered columnar complexes with a range of inter-DNA spacings 
from aHexamineCo = 2π/qHexamineCo = 2.43 nm for Hexamine cobalt (III) to aG3 = 2π/qG3 = 4.37 nm 
for PAMAM dendrimer G3 (Fig. 1b). A crucial criterion for pDC activation in these DNA 
complexes is the inter-DNA spacing: Strong IFN-α responses are induced by complexes with 
first peak positions between 1.8-2.0 nm-1 corresponding to inter-DNA spacings near a ~ 3.5 nm 
(Fig. 1b), whereas complexes with a spacings that deviate from this value induce weaker 
6 
 
responses. Changes in salt levels over the range of physiological concentrations present in 
endosomes did not alter the structures of representative polycation-DNA complexes or their 
inter-DNA spacings to a degree sufficient to change activation profiles (Supplementary Fig. S2). 
Importantly, DNA complexed with polycations that induce strong and those that induce weak 
IFN-α responses both can access endosomes and colocalize with TLR9 (Fig. 2). The 
colocalization of non-inducing complexes with TLR9 demonstrates that cellular entry and 
trafficking cannot be solely responsible for their lack of activity. The efficiency of endosomal 
access may, in principle, modulate the degree of IFN-α response of polycation-DNA complexes 
that induce IFN-α production. These results show that the presentation of spatially periodic DNA 
with spacing comparable to TLR receptor size can drastically increase IFN-α production by 
pDCs. The ‘sweet spot’ of 3-4 nm spacing is suggestive. The low distance cut-off is roughly the 
steric size of TLR receptors15-17, which defines the distance of closest approach between 
receptors. The large distance cut-off is consistent with strong electrostatic interactions expected 
in this system, which allows anionic DNA to interact with both the inside and outside surfaces of 
adjacent cationic TLR9 receptors, and thereby ‘crosslink’ such receptors into a zipper-like 
ligand-receptor array (Fig. 1 c&d). To test the plausibility of these explanations for the striking 
observations in Figure 1, we will need to construct a suitable quantitative model.  
 
Since a single ordered columnar DNA complex (‘DNA bundle’) can bind transversely and 
effectively present a spatially-periodic ‘grill’-like array of parallel DNA chains to multiple TLR9 
receptors, there is potential for multivalent binding effects (Fig. 1d). The degree of multivalency 
can be estimated via the measured domain size (Fig. 3a) of DNA ordering (Fig. 3b-e). Generally, 
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in systems where ligands are able to form multiple weak bonds with target receptors, one can 
expect to observe ‘super-selectivity’, i.e. binding increasing sharply with receptor 
concentration11. Binding of immune complexes to TLR9 receptors is more complex, and depends 
sensitively on inter-DNA spacing in the bundle; we observe a dramatic ~100-fold change in IFN-
α production as the distance between DNA chains in a complex shifts ~ 0.5 nm. These systems 
are at present not accessible to all-atom simulations. Therefore, to investigate the origin of TLR9 
amplification, we developed a coarse-grained computational model.  
 
We first consider binding of TLR9 receptors to an isolated DNA chain. If there are κ available 
binding sites on DNA to which receptors can attach, the expected number of receptors, nB, that 
are actually bound to the DNA is less than κ: 
  (1) 
where ε is the binding free energy of receptors to DNA, which depends on DNA-TLR9 
interactions and on the density of receptors on the membrane (see Model in Supplementary 
Information). In the case of weak binding, , this simplifies to . For ε ≈ 4 
kBT, the TLR9 receptors will cover less than 2% of an isolated DNA chain. When DNA chains 
are arranged into a bundle, however, the electrostatic interactions between TLR9 molecules and 
DNA are different: Each cationic TLR9 molecule can now interact with three anionic DNA 
chains (Fig. 4a), the one in the TLR9 binding groove, and the two immediately adjacent to it. 
The effective binding free energy is then: 
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  (2) 
where U(a) is a sum of all additional interactions between a TLR9 molecule and an adjacent 
DNA chain (electrostatic interaction is represented by the screened Yukawa potential and steric 
repulsion between TLR9 and DNA by the Lennard-Jones 12 term, see Model and Fig. S4 in 
Supplementary Information). The binding free energy ε* to a bundle decreases (binding becomes 
stronger) when the spacing between DNA is reduced – until the spacing is so small that steric 
effects become important. The binding is strongest for commensurately spaced DNA chains that 
allow ‘interdigitation’ between TLR9 and the periodic DNA array, where multiple receptors and 
ligands interlock in an alternating manner. Such optimal ordered structures can recruit and bind 
many TLR9 molecules (Fig. 4b and Supplementary Fig. S4) and trigger an orders of magnitude 
stronger pDC response than the mismatched structures.  
 
To test this hypothesis, we performed Monte Carlo simulations to determine the equilibrium 
number of bonds, nB(a), formed between TLR9 receptors and a DNA array with set ligand 
number κ = 6 (extracted from the LL37-DNA domain size, Fig. 3a) and given spacing a. For 
strong binding (ε < 2 kBT), the number of formed bonds does not depend strongly on DNA 
spacing; nB is appreciable for expanded bundles with large a. This regime is inconsistent with 
our observations (Fig. 1b) since bundles with large a (small q) do not induce high amounts of 
IFN-α production (see Supplementary Note S7). In the weak binding scenarios, ε =3 kBT, 5 kBT 
and 7 kBT, the curves follow the experimental trend and exhibit a pronounced maximum at 
2π/a*≈ 2 nm-1 (Fig. 4b), corresponding to the optimal lattice spacing a*≈ 3 nm. These conditions 
)(2* aU+= εε
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approach the close-packing limit for DNA chains and TLR9. At smaller spacing, steric repulsion 
prevents binding and leads to the sharp decrease in nB. Therefore, the self-organization of an 
interlocking receptor-ligand array strongly enhances binding of DNA bundles to TLR9 receptors.  
 
The single TLR9-DNA bonds are relatively weak, but their number nB increases significantly 
with the decreasing lattice spacing – up to a ratio nB(a*)/nB(∞) of approximately 5 to 10. The 
possibility to form many weak bonds increases dramatically the combinatorial entropy and thus 
decreases the free energy F(a) for DNA bundles binding to the receptor-decorated membrane. 
The number of all active (i.e. bound to DNA) receptors is determined by the product of the 
number of bound DNA bundles and the average number of bonds each bound bundle makes with 
receptors: 
  (3) 
Accounting for these different layers of statistical mechanical effects from multivalent binding, 
one can clearly see (Fig. 4c) that the response of the cell from receptor activation, NA(a), 
becomes strongly amplified. This can be seen in a Langmuir-like analytical model (see 
Analytical theory in Supplementary Information) that predicts exponential scaling of nB(a) with 
the binding strength, while the total activation NA(a) shows a much stronger double-exponential 
dependence18. The degree of selectivity can be defined as a ratio of cell activation in optimally 
condensed (a = a*) and expanded (a→∞) bundles:  
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  (4) 
Experimental observations predict γ ≈ 100 (Fig. 1b), which agrees with numerical simulations 
and theory based on this plausibility model with a reasonable choice of parameters (Fig. 4d). 
Moreover, these results are robust: The same trends are observed qualitatively when effects from 
monovalent salt (Supplementary Fig. S5) and noise (allowing the DNA to diffuse about their 
average position in the 2D lattice) (Supplementary Fig. S6) are incorporated into the simulations. 
 
The simplified quantitative model above strongly suggests that electrostatic self-assembly 
between DNA, cationic ligands, and TLR9 can drive a drastic amplification of the number of 
active receptors. Importantly, TLR9 activation depends on both the inter-DNA spacing and the 
number of DNA ligands in the complex, since both factors contribute strongly to multivalency 
and binding amplification. The above effects can operate in concert with other processes such as 
protection from enzymatic degradation10, receptor cooperativity19, and downstream 
consequences of active TLR9 receptors.  
 
In vitro experiments have used cationic liposomes to form DNA complexes that are internalized 
in dendritic cells and transfected cell lines to modulate TLR9 activation1,6,20, but the microscopic 
mechanism is not understood. Consistent with our model, cationic lipids can also organize DNA 
into a rich polymorphism of spatially-periodic structures, including 2-D lamellar structures with 
tunable inter-DNA spacings21,22. The emerging picture implies that pDC activation is not 
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deterministically controlled by uncorrelated binding between individual ligands and receptors; 
rather, the induced organization of immune ligands into optimal periodic structures can result in 
massive binding enhancement, and thereby strongly amplify immune response.  
 
Although our explanatory model is relatively simple, the empirical results described here have 
broad implications for controlling immune response. It will be interesting to determine whether 
natural AMPs can bind to and organize DNA fragments from permeated pathogens, and thereby 
enable multivalent presentation to TLR9 and promote adaptive immune responses. Since TLR9 
activation is highly sensitive to inter-DNA spacing in ordered electrostatic complexes, 
knowledge of their structures can inform immunotherapies. The data here suggest that cationic 
proteins, peptides, or other cationic agents less than 0.5 nm in size or greater than 2.0 nm in size 
do not activate TLR9, since steric constraints will prevent them from forming a TLR9-DNA 
zipper. The behavior of cationic proteins or peptides in the intermediate size regime between 0.5 
nm and 2.0 nm can be engaged via straightforward computer simulations23 if the structures are 
known, since electrostatic binding in aqueous environments depend on charge distribution, 
shape, and binding orientation of the protein. Importantly, these results suggest that TLR9 
activation can be attenuated by engineering the inter-DNA spacing to suppress the receptor-
ligand zipper arrays via competitive binding, and potentially suppress inflammation in 
autoimmune diseases like psoriasis. Likewise, by leveraging fundamental understanding of 
electrostatic self-assembly23,24, we can deterministically trigger immune responses in the context 
of vaccines, and predict which synthetic nano-sized objects are likely to induce adventitious 
inflammatory response, with strong implications for nanotoxicology.  
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Methods  
Self-assembled DNA complexes preparation. For SAXS, monodispersed Lambda DNA 
(BioLabs) is precipitated and resuspended in aqueous solution, at 100mM NaCl or a buffer 
composed of 10mM HEPES  and 100 mM NaCl adjusted to pH = 7.4, 5.4 or 5.0, depending on 
the condensing agent. Self-DNA was used in the cell experiments. Peptide-based cationic agents 
(≥ 95% purity, Anaspec) include: R9 (RRRRRRRRR), poly K (MW ~ 70,000), TAT 
(YGRKKRRQRRR), hBD3d derivative (KSSTRGRKSSRRKK), NLS (PKKKRKV), ANTP 
Penetratin (RQIKIWFQNRRMKWKKGG), HBD3 
(GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK), and human LL37 
(LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES). Non-peptide based cationic agents 
include cobalt hexamine, cobalt Tris(ethylenediamine), protamine sulfate, Polyethyleneimine 
(MW ~ 750,000), PAMAM Dendrimer (G3, G4, G6), which are all used without further 
purification.  Complexes were formed between each cationic agent and DNA by incubating the 
agent with DNA (10 mg/ml for SAXS, 10 µg/ml for cells) at specific charge ratios. For a given 
cationic agent the same charge ratios were used in both SAXS and cell experiments.  
 
Cell Experiments 
pDC isolation and stimulation.  Human blood pDCs were isolated from buffy coats obtained 
from the blood of healthy donors at the Service Regional Blood Bank, Lausanne, Switzerland. 
After separation of mononuclear cells by Ficoll centrifugation, pDCs were purified by using a 
PDC negative selection cocktails (Plasmacytoid dendritic cell isolation kit II) to reach 99% 
purity. Purified pDCs were seeded into 96-well round-bottom plates at 5 x 104/well in 200 µl 
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RPMI 1640 (GIBCO, Carlsbad, CA) supplemented with 10% fetal calf serum (FCS) (Atlanta 
Biologicals, Lawrenceville, GA). Supernatants of stimulated pDCs were collected after overnight 
culture. Cytokine levels in the supernatants were determined by using ELISA kits for human 
IFN-α (PBL Biomedical Laboratories, New Brunswick, NJ). 
 
Uptake of complexes. Uptake of DNA complexes by pDCs was visualized by using human 
DNA (BioChain, Hayward, CA) labeled with AlexaFluor488 by using the Ulysis Nucleic Acid 
Labeling Kit (Molecular Probes, Carlsbad, CA), according to the standard protocol provided by 
the manufacturer as previously described. After 4 h of pDC stimulation with DNAAlexa488 -
containing complexes, stimulated pDC were washed and the percentage of Alexa488-positive 
cells was determined by flow cytometry. Self-DNA was used at 10 µg/ml. 
 
Normalized IFN-α production. To provide a more accurate view of the ability of DNA 
complexes to trigger endosomal TLR9 activation, IFN-α levels were normalized by the 
percentages of pDC that have actually internalized the complexes. The normalization controls for 
variations in IFN-α production due to variations in the uptake of these complexes by pDCs. 
Uptake of DNA complexes was conducted as described in “Uptake of complexes” section. 
 
Cell staining and imaging of endosomal trafficking. pDCs were stimulated with 
AlexaFluor488-labelled CpG 2006 (Trilink) in complex with the following cationic peptides: 
LL37, hBD3d, TAT46-60, and non-peptide cationic molecules: tris(ethylenediamine) cobalt, 
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hexamine cobalt. Cells were washed after 1h of stimulation and further incubated for a total of 
4  h, transferred onto coverslips pretreated with poly-lysine, fixed for 15  min in 4% para-
formaldehyde, and permeabilized in PBS supplemented with 0.5% Triton X 100 (Sigma-Aldrich) 
and 1% normal goat serum (Jackson ImmunoResearch Laboratories). Samples were then stained 
with a rat anti-human TLR9 (CD289) (eBiosciences) together with a mouse anti-human 
transferrin-receptor (CD71) (eBiosciences) monoclonal antibodies followed by AlexaFluor546-
labelled anti rat (Invitrogen) and AlexaFluor647-labelled anti-mouse (Life Technologies) in 
permeabilization buffer. Slides were washed and mounted in Prolong Gold antifade mounting 
media (Molecular Probes) before imaging.  
 Imaging was performed using a Zeiss LSM 710 laser scanning confocal microscope with 
an oil immersion objective (63×/1.4 numerical aperture). 
 
SAXS experiments 
SAXS measurements. We measure a phase diagram for complexes formed between each 
cationic agent and DNA, by incubating them with DNA (10 mg/ml) at specific charge ratios. 
After thorough mixing and centrifugation, the complexes are hermetically sealed in 1.5 mm 
quartz capillaries (Hilgenberg GmbH, Mark-tubes, Code No: 4017515, & Charles Supper Co., 
MA). SAXS measurements were performed at beamline 4-2 of the Stanford Synchrotron 
Radiation Laboratory (SSRL; Menlo Park, CA). Monochromatic X-rays with energies 9-12 keV 
were used. A Rayonix MX225-HE detector (pixel size 73.2 × 73.2 µm) was used to collect the 
scattered radiation. Samples were also measured using the California NanoSystems Institute 
(CNSI) SAXS spectrometer at UCLA (incident wavelength, λ = 1.54 Å) and a MAR345 image 
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plate detector (pixel size 150 × 150 µm). Identical samples were prepared and measured at 
different times after preparation using multiple light sources to ensure consistency in data. The 
2D SAXS powder patterns were azimuthally integrated using the Nika 1.48 package 
(http://usaxs.xor.aps.anl.gov/staff/ilavsky/nika.html) for Igor Pro 6.22 and Fit2D 
(http://www.esrf.eu/computing/scientific/FIT2D/). 
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Figure 1| Interferon IFN-α production in dendritic cells through TLR9 activation depends 
on DNA spacing in electrostatic DNA complexes formed with polycations. a, Representative 
SAXS data from peptide-DNA complexes that induce strong IFN-α production in dendritic cells 
(DNA with the antimicrobial peptide HBD3) and those that do not (DNA with TAT cell-
penetrating peptide). Higher order reflections for the TAT-DNA hexagonal lattice are shown in 
the upper right corner.  b, IFN-α production by pDCs stimulated with polycation-DNA 
complexes, normalized for the amount of complex internalization, shows a strong 
correspondence with SAXS measurements of their first diffraction peak q-positions. Since the 
first peak position is inversely proportional to the inter-DNA spacing, a narrow range of inter-
DNA spacings result in high IFN-α production levels. Inset and shading are included to 
distinguish HBD3 and G6 bars. c, Illustration of the TLR9-dsDNA complex whose structure is 
unknown, based on the solved structure of (homologous) TLR3 complexed with dsRNA15,16. d, 
Different DNA spacings can impact TLR9 activation. Larger geometric spacings (top) between 
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orientationally-ordered DNA in the bundle can accommodate binding of multiple TLR9s and 
amplify activation, while smaller spacings (bottom) subdue activation since they sterically 
reduce accessibility of bundled DNA to receptors. Shading differences of adjacent TLR9 
molecules indicate that they are offset along the columnar DNA lattice. 
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Figure 2| Both IFN-inducing and non IFN-inducing cationic molecules transport DNA to 
endosomal TLR9. PDCs were stimulated for 4h with CpG-2006 (AlexaFluor488) 
oligonucleotides complexed with either IFN-inducing (LL37) or non IFN-inducing cationic 
molecules (hBD3d, TAT, Tris-ethylenediamine Cobalt, hexamine Cobalt (III). Early endosomes 
were stained with AlexaFluor647-labelled anti-transferrin receptor (CD71) along with an 
AlexaFluor546-labelled anti-TLR9. Cell nuclei were stained with DAPI and the contour of the 
cells was visualized by transmitted light in panel a. a, Colocalization between TLR9 and 
endocytic compartments is shown by the arrows. b, Panel shows that DNA (AlexaFluor488) 
complexed with IFN-inducing and non IFN-inducing molecules colocalize with TLR9 
(AlexaFluor546), as highlighted by the arrows. 
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Figure 3| The presentation of ordered columnar DNA complexes, with specific inter-DNA 
spacings. a, Representative SAXS spectra from LL37 complexed with DNA. Diffraction peaks 
are observed at q10 = 1.85 nm-1, and q11 = 2.68 nm-1 which have the ratio, 1:√2, characteristic of 
a square lattice with parameter a = 3.40 nm. The average linear domain size of LL37-DNA 
bundles is extracted from the fitted width, w, of the (10) peak (see SAXS data fits in 
Supplementary Information). Schematic representations of the four main structural types of 
DNA-polycation complexes observed in this study: the LL37-DNA columnar square lattice, b, 
the TAT-DNA columnar hexagonal lattice, c, and disordered columnar arrangements of DNA 
with larger inter-DNA spacing such as DNA complexed with HBD3, d, or smaller spacing that is 
consistent with DNA complexed with Tris(ethylenediamine) cobalt, e. LL37-DNA complexes 
with inter-DNA spacings a ~ 3.5 nm induce much greater IFN-α production in pDCs compared 
with tightly-packed TAT-DNA complexes with inter-DNA spacings of a ~ 2.9 nm.  
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Figure 4| Coarse-grained model of TLR9 binding to DNA bundles exhibits ‘super-selective’ 
behavior in agreement with experimental observations. a, Schematic representation of the 
model: DNA are uniformly charged rods arranged in an ordered ‘grill’-like array with lattice 
spacing a. This mimics a DNA bundle binding to receptors on a membrane sideways. TLR9 are 
represented in projection as S-shaped ‘tetris blocks’ with two arms of length σ, width σ/3, and 
uniform charge density opposite to that of DNA. b, Equilibrium number of bonds, nB, as a 
function of inverse lattice spacing q=2π/a, for various binding free energies ε, at TLR9-DNA 
electrostatic interaction B = AZ1Z2kBT = 30 kBT, where Z1,2 are effective charges and A is a 
constant. Two simulation snapshots from ε = 3 kBT further illustrate bond statistics. c, Total 
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number of active receptors, NA, as a function of q at B = 30 kBT. Multivalency increases the 
lattice-spacing-selective response. d, The peak-to-plateau ratio, γ = NA(a*)/NA(∞), characterizing 
the degree of selectivity (see Supplementary Note S8). Symbols are from numerical simulations; 
solid lines represent the Langmuir theory, and dashed lines are a double-exponential 
approximation to the full theoretical expression (see Analytical theory in Supplementary 
Information). Large γ are observed over a range of different B and ε. Gray shaded area marks the 
parameter values that correspond to experiments. 
